Evangéline P.
- Country
- France
- Department
- Service de Néphrologie
Research Overview
- Long-term safety and tolerability of zigakibart in adults with primary IgA nephropathy: an open-label extension study
- Phase II Study of Obinutuzumab in Patients with Systemic Lupus Erythematosus Pure Membranous Nephropathy (Class V Lupus Nephritis)
- Evaluation of Ravulizumab Efficacy and Safety in Adult Patients with Immunoglobulin A Nephropathy: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 86 of 254 partner sites.
Specializations
Glomerular Diseases
Specialized focus on IgA Nephropathy (IgAN) management and treatment strategies, including investigation of novel therapeutic approaches with agents like ravulizumab, atacicept, and hydroxychloroquine for preserving kidney function and reducing proteinuria.
- IgA Vasculitis Treatment
- Proteinuria Management
- Glomerular Function Assessment
Additional expertise in lupus nephritis treatment protocols, particularly exploring steroid-free regimens combined with immunomodulatory therapies.
Inflammatory Conditions
Expert in treating ANCA vasculitis and its complications, with particular attention to immunosuppression management in end-stage renal disease patients. Research extends to gout management in patients with complex kidney conditions.
- Vasculitis Treatment Protocols
- Inflammatory Response Management
- Immunosuppressive Therapy Optimization
Focused investigation of interleukin-1 antagonist therapy for inflammatory conditions in renal patients.
Chronic Kidney Disease
Extensive work in advanced renal disease management, encompassing stages 3b through 5, including specialized care for transplant recipients and dialysis patients.
- Transplant Patient Care
- End-Stage Renal Disease
- Therapeutic Innovation
Integration of novel biological therapies and conventional treatments for optimal renal outcomes in complex cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.